Expert Illustrations & Commentaries™: Envisioning New Therapies for Meibomian Gland Dysfunction-Associated DED

Release Date: December 22, 2022

Expiration Date: December 22, 2023

Activity Overview

This Expert Illustrations and Commentaries™ is a video-based program in which two experts discuss the management of meibomian gland dysfunction (MGD)-associated dry eye disease (DED). In this activity, the faculty focus on the etiology of MGD-associated DED and current and emerging therapeutic strategies for its management. Their discussion is enriched with the use of video animation to illustrate the pathophysiology of MGD and mechanisms of action of emerging agents. The use of these animated segments helps make somewhat complicated subject matter more easily understood. This unique format is designed to help clinicians identify best practices in the diagnosis and management of MGD-associated DED and to improve outcomes for their patients with this disease.

Target Audience

This educational activity is directed towards ophthalmologists, optometrists, and other health care professionals involved in the treatment of patients with dry eye disease and meibomian gland dysfunction.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Describe the impact that MGD-associated DED has on patients’ quality of life
• Assess the efficacy and safety of currently available agents used for the treatment of MGD-associated DED
• Identify the MOAs of new and emerging agents for the treatment of MGD-associated DED
• Evaluate clinical trial data for new and emerging agents in the treatment of MGD-associated DED

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.